Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Transforming growth factor-beta and extracellular matrix deposition in the kidney.

Literature DB >> 8004960

Transforming growth factor-beta and extracellular matrix deposition in the kidney.

W A Border¹, D Brees, N A Noble.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 1994 PMID： 8004960 DOI： 10.1159/000422972

Source DB: PubMed Journal: Contrib Nephrol ISSN： 0302-5144 Impact factor: 1.580

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

Review 1. Extracellular matrix and the kidney.

Authors: P N Furness
Journal: J Clin Pathol Date: 1996-05 Impact factor: 3.411

2. Nanolayered siRNA delivery platforms for local silencing of CTGF reduce cutaneous scar contraction in third-degree burns.

Authors: Steven A Castleberry; Alexander Golberg; Malak Abu Sharkh; Saiqa Khan; Benjamin D Almquist; William G Austen; Martin L Yarmush; Paula T Hammond
Journal: Biomaterials Date: 2016-04-14 Impact factor: 12.479

3. Acceleration of wound healing in gastric ulcers by local injection of neutralising antibody to transforming growth factor beta 1.

Authors: H Ernst; P Konturek; E G Hahn; T Brzozowski; S J Konturek
Journal: Gut Date: 1996-08 Impact factor: 23.059

4. Biochemical Markers of Bone Turnover in Older Adults With Type 1 Diabetes.

Authors: Mishaela R Rubin; Ian H de Boer; Jye-Yu C Backlund; Valerie Arends; Rose Gubitosi-Klug; Amisha Wallia; Naina Sinha Gregory; Annette Barnie; Andrew J Burghardt; John M Lachin; Barbara H Braffett; Ann V Schwartz
Journal: J Clin Endocrinol Metab Date: 2022-05-17 Impact factor: 6.134

Review 5. Pathophysiology of the diabetic kidney.

Authors: Volker Vallon; Radko Komers
Journal: Compr Physiol Date: 2011-07 Impact factor: 9.090

Review 6. Diabetic kidney disease: update on clinical management and non-glycaemic effects of newer medications for type 2 diabetes.

Authors: Áine M de Bhailís; Shazli Azmi; Philip A Kalra
Journal: Ther Adv Endocrinol Metab Date: 2021-05-29 Impact factor: 3.565

7. Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis.

Authors: Vasundhara Kain; Sandeep Kumar; Sandhya L Sitasawad
Journal: Cardiovasc Diabetol Date: 2011-11-04 Impact factor: 9.951